1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341:1284-1291.
2. Brunning RD, Germing U, Le Beau MM, et al. Myelodysplastic syndromes/neoplasms, overview. In: Swerd Low SH, Harris NL, Jaffe ES, . eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008:88-93.
3. Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991;18:721-727.
4. Ohno E, Ohtsuka E, Watanabe K, et al. Behçet’s disease associated with myelodysplastic syndromes: a case report and a review of the literature. Cancer 1997;79:262-268.
5. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Behçet’s disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 2006;24(5 Suppl 42): S115-S119.
6. Handa T, Arai Y, Mitani K. Myelodysplastic syndrome associated with intestinal tract-type Behçet disease characterized by an esophageal ulcer. Rinsho Ketsueki 2004;45:1135-1137.
8. Handa T, Nakatsue T, Baba M, Takada T, Nakata K, Ishii H. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet’s disease. Respir Investig 2014;52:75-79.
9. Hulscher JB, van den Berg HP, Siegert CE, Steller EP. A Turkish man with Behçet disease and recurrent acute abdomen. Ned Tijdschr Geneeskd 2003;147:1969-1971.
10. Kurata M, Nozue M, Seino K, Murata H, Sumita T, Katashi F. Indications for surgery in intestinal Behçet’s disease. Hepatogastroenterology 2006;53:60-63.
11. Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Early versus late surgery in patients with intestinal Behçet disease. Dis Colon Rectum 2012;55:65-71.
12. Byeon JS, Choi EK, Heo NY, et al. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet’s disease: report of a case. Dis Colon Rectum 2007;50:672-676.
13. Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis 2011;17:1594-1602.
14. Iida M, Kobayashi H, Matsumoto T, et al. Postoperative recurrence in patients with intestinal Behçet’s disease. Dis Colon Rectum 1994;37:16-21.
15. Kawano S, Hiraoka S, Okada H, Akita M, Iwamuro M, Yamamoto K. Clinical features of intestinal Behçet’s disease associated with myelodysplastic syndrome and trisomy 8. Acta Med Okayama 2015;69:365-369.
16. Wada Y, Nakatsue T, Kuroda T, et al. A case of intestinal Behcet’s disease complicated with myelodysplastic syndrome (MDS) refractory to anti-TNF drug treatment after bone marrow transplantation. J Chubu Rheumatism Association 2015;45:45-46.
18. Nishimura K, Fujiki R, Hirotsu J, et al. A case of hilar bile duct cancer with intestinal Behçet’s disease. Kurume Med J 2004;51:169-173.
19. Higa A, Uezu Y, Shiohira Y. A case of intestinal Behcet’s disease with perforation early onset. Kyushu J Rheumatology 2003;22:110-114.
20. Arhan M, Ibiş M, Koklu S, Ozin Y, Oymaci E. Behcet’s disease complicated with descending colon perforation. Dig Surg 2005;22:381.